ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,404.02
0.10%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vir Biotechnology Inc (VIR)

  7. Vir Biotechnology Inc (VIR) Noticias

VIR Vir Biotechnology Inc

11.23
-0.75 (-6.26%)
07 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Vir Biotechnology Inc VIR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.75 -6.26% 11.23 23:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.78 11.015 11.81 11.23 11.98
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/6/202405:04EDGAR2Form 8-K - Current report
05/6/202404:30BWTobevibart Monotherapy and Combination Therapy with..
03/6/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202410:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/5/202413:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202413:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/5/202415:06EDGAR2Form 8-K - Current report
29/5/202415:05BWVir Biotechnology to Participate in the Goldman Sachs 45th..
29/5/202407:05BWVir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as..
23/5/202415:05BWVir Biotechnology to Host 2024 Annual Meeting of..
22/5/202407:05BWMultiple Abstracts Highlighting Vir Biotechnology’s Latest..
21/5/202407:17BWVir Biotechnology Announces SOLSTICE Data to be Featured as..
14/5/202415:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/5/202415:05BWVir Biotechnology Provides Corporate Update and Reports..
30/4/202415:05BWVir Biotechnology to Participate in the BofA Securities..
18/4/202407:00BWVir Biotechnology Announces Nomination of Norbert..
11/4/202415:30BWVir Biotechnology to Provide Business Update and Report..
05/3/202407:05BWVir Biotechnology Completes Enrollment of Phase 2 Chronic..
26/2/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202418:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202418:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202418:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202407:05BWVir Biotechnology to Participate in Upcoming Investor..
22/2/202415:12EDGAR2Form 8-K - Current report
22/2/202415:05BWVir Biotechnology Provides Corporate Update and Reports..
20/2/202415:33EDGAR2Form 8-K - Current report
20/2/202415:30BWVir Biotechnology Announces Dr. Phil Pang Will Step Down as..
16/2/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:05BWVir Biotechnology to Provide Business Update and Report..
03/1/202413:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202304:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
13/12/202315:06EDGAR2Form 8-K - Current report
13/12/202315:05BWVir Biotechnology Announces Strategic Steps to Reduce..
06/12/202315:05BWVir Biotechnology to Present at J.P. Morgan 2024 42nd Annual..
13/11/202307:00BWVir Biotechnology to Present New Data from Its Ongoing Phase..
10/11/202307:00BWVir Biotechnology to Present Late-Breaking Data from Its..
08/11/202307:05BWVir Biotechnology Ranked the Fastest-Growing Company in..
03/11/202315:37EDGAR2Form 8-K - Current report
03/11/202315:33EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03/11/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:09EDGAR2Form 8-K - Current report
02/11/202315:05BWVir Biotechnology Provides Corporate Update and Reports..
30/10/202307:00BWVir Biotechnology Appoints Jennifer Towne, Ph.D., as..
12/10/202315:05GLOBEVir Biotechnology to Participate in the H.C. Wainwright 4th..
11/10/202307:00GLOBEVir Biotechnology Announces Multiple Abstracts Highlighting..
05/10/202315:30GLOBEVir Biotechnology to Provide Business Update and Report..
03/10/202307:01EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
VIR
Vir Biotechnology
TG
ESD
BGC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados